Preview
Link Preview
News-Medical.net
MHRA authorizes new version of the Moderna ‘bivalent’ Covid vaccine
Authorization has today been granted by the Medicines and Healthcare products Regulatory Agency (MHRA) for a new version of the Moderna 'bivalent' Covid vaccine (Spikevax) that targets both the original strain of SARS-CoV-2 and the Omicron BA.4 and BA.5 sub-variants.
Authorization has today been granted by the Medicines and Healthcare products Regulatory Agency (MHRA) for a new version of the Moderna 'bivalent' Covid vaccine (Spikevax) that targets both the original strain of SARS-CoV-2 and the Omicron BA.4 and BA.5 sub-variants.
Issue #2
False information.
- Type of issue
- Submitted via the Previews bot
- Reported
- Feb 23, 2023